Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature
Pharmacopsychiatry · 01.03.2024 · 57 (02) · 78-81
DOI: 10.1055/a-2262-8297 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacopsychiatry, erschienen am 01.03.2024. Verfasst von Dhouha Sahnoun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacovigilance, University of Sousse, Tunisia. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Antipsychotics can cause hematologic disorders, and they can have life-threatening consequences. Risperidone, less commonly associated with hematologic adverse effects, is an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and irritability associated with autism. While risperidone primarily affects the central nervous system, it can have some hematologic adverse effects, although these are relatively rare. It is crucial to note that these side effects are not common, and most people taking risperidone do not experience hematologic disorders. The reporting of such disorders may be more frequent with clozapine compared to other atypical antipsychotics because clozapine treatment necessitates regular hematological monitoring 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacovigilance, University of Sousse, Tunisia.
- Department of Psychiatry, Farhat Hachad Hospital, Sousse University, Tunisia.
ORCID-Profile: Dhouha Sahnoun
Zitieren
APA
Sahnoun, D., Ghanmi, A., Gazzeh, S., Saguem, B., Slim, R., Nakhli, J., & Ben Salem, C. (2024). Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature. Pharmacopsychiatry, 57(02), 78-81. https://doi.org/10.1055/a-2262-8297
Vancouver
Sahnoun D, Ghanmi A, Gazzeh S, Saguem B, Slim R, Nakhli J, et al. Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature. Pharmacopsychiatry. 2024;57(02):78-81. doi:10.1055/a-2262-8297
BibTeX
@article{Sahnoun2024,
author = {Sahnoun, Dhouha and Ghanmi, Ahlem and Gazzeh, Soumaya and Saguem, Bochra and Slim, Raoudha and Nakhli, Jaafar and Ben Salem, Chaker},
title = {Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature},
journal = {Pharmacopsychiatry},
year = {2024},
volume = {57},
number = {02},
pages = {78--81},
doi = {10.1055/a-2262-8297}
}
EUVIMED